The pattern of diabetic admissions in UCTH Calabar, South Eastern Nigeria: A five year review

Background: The world's adult population is increasing rapidly. This increase is expected to lead to an increase in the prevalence of diabetes especially in developing countries like Nigeria. Diabetes places a large burden on the society more so when it becomes complicated. Thisstudy is designed to provide information on hospitalisation trends and their outcomes among diabetic patients.Methods: This was a 5 year retrospective analysis of hospitalisation trends and outcomes among diabetics admitted into the medical wards of UCTH Calabar between January 2006 and December 2010. Information was obtained from their case files and data was analysed using SPSS version 18 soft ware.Results: A total of 3490 patients were admitted into the medical wards during the period under review. Diabetes accounted for 360 (9.64%) of admissions. The average age of the subjects was 48.5 ± 14.0 years. The mean duration of Diabetes was 11 ± 7.2 years (range 1-32 years). HHS was the most frequent indication for admission (35.8%) followed by DKA (21.7%) and diabetic foot syndrome (15.8%). The duration of hospitalisation ranged from 1 to 150 days with an average of 18.7 ± 18.8 days. Mean duration of hospitalisation was longest for diabetic foot syndrome (38.5 ± 36.4 days) and least for UTI (7.3 ± 5.0 days). Three hundred and nine patients (85.8%) were treated and discharged while 48 (13.3%) left against medical advice and 3 (0.8%) died while on admission. A majority of patients who left against medical advice were admitted for DFS (50.0%). 53.3% of the patients had blood pressure above 140/90 on admission and 69% of the subjects were non-compliant with their treatment.Conclusion: Diabetes is a major cause of hospitalisation in our hospitals and most of the complications are preventable. With proper patient education and adherence to management, the burden of DM can be reduced in our society

Resource use in sweet potato production in delta state, nigeria: a technical efficiency approach

Sweet potato is one of the major staple crops in Nigeria and most parts Africa sub-region. Its importance continues to rise due to increased urbanization. This increase definitely come with its share of challenges that need to be addressed. The study was conducted within the framework of the rural farming households who constitute the backbone of the Nigerian agricultural sector, producing about 80 per cent of the total national agricultural output. It examined resource use in sweet potato production in Delta state, Nigeria. The specific objectives are to determine the technical efficiency of sweet potato farmers, assess the factors determining the technical efficiency of potato farmers and to determine the technical efficiency distribution of sweet potato farmers. Multi-stage random sampling technique was adopted to select 120 respondents and stochastic frontier production function employed to realize the objectives. Result of analysis showed that the least technically efficient farmers have to increase their level of production given their inputs and technology to at least 68 % for them to operate at the production frontier while the most technically efficient farmers have to increase their production to at least by 4% for them to operate on the production frontier and be fully efficient with a mean technical efficiency of 0.71. The estimates of the parameters of the production function (sweet potato seeds, labour, fertilizers and agrochemical) were positive and significant at 5% and 1% levels respectively, while capital input was positive and not significant.  Factors affecting technical inefficiency of sweet potato farmers among others included: age of farmers and farm size which were negative and significant, while household size, educational qualification, type of cropping and farming experience were all positive and significant. The following recommendations were proffered: sweet potato farmers should have access to improved sweet potato varieties, modern storage technologies, markets and extension services. Adequate financial assistance and credit facilities should also be made available to the sweet potato farmers to enable them expand their crop output

The Catalytic Role of Hotel Industry in Sustainable Tourism Development in Calabar, Nigeria

Today, the need for tourism development has  been advocated by the various stakeholders and scholars in this great industry. The driving mechanism towards this challenge is predicated upon the in availability of other sub-systems that will  pilot this laudable industry and make it more viable. This paper critically focus on the  hotel industry as a panacea for sustainable  tourism development in Calabar. A total of one hundred and twenty seven (127) hotels were assessed and the data were analyzed using the Pearson' Moment Correlation and the correlation coefficient of 0.89 and coefficient determination of 0.62 were obtained. This means that 62% of the variation in the growth of hotels is contributed to the increase in the number of tourist influx in Calabar. This result therefore, shows that the hospitality industry vis-à-vis the hotel industry is capable of shouldering the challenges and also boosting  the image of tourism in Cross River State in general and Calabar in particular. Therefore, if hotel industry and tourism must be sustained, a mechanism must be put in place that would ensure tourism  related  activities al l year round in Calabar

Sero-epidemiological survey and risk factors associated with bovine brucellosis among slaughtered cattle in Nigeria

Bovine brucellosis is endemic in Nigeria; however, limited data exist on nationwide studies and risk factors associated with the disease. Using a cross-sectional sero-epidemiological survey, we determined the prevalence of and risk factors for brucellosis in slaughtered cattle in three geographical regions of Nigeria. Serum samples from randomly selected unvaccinated cattle slaughtered over a period of 3 years (between December 2010 and September 2013) from northern, southern and south-western Nigeria were tested for antibodies to Brucella abortus using the Rose Bengal test. Data associated with risk factors of brucellosis were analysed by Stata Version 12. In all, 8105 cattle were screened. An overall seroprevalence of 3.9% (315/8105) was recorded by the Rose Bengal test, with 3.8%, 3.4% and 4.0% from the northern, southern and south-western regions, respectively. Bivariate analysis showed that cattle screened in northern Nigeria were less likely to be seropositive for antibodies to Brucella spp. than those from south-western Nigeria (odds ratio = 0.94; 95% confidence interval: 0.73–1.22). However, logistic regression analysis revealed that breed ( p = 0.04) and sex ( p £ 0.0001) of cattle were statistically significant for seropositivity to Brucella spp. The study found that brucellosis was endemic at a low prevalence among slaughtered cattle in Nigeria, with sex and breed of cattle being significant risk factors. Considering the public health implications of brucellosis, we advocate coordinated surveillance for the disease among diverse cattle populations in Nigeria, as is carried out in most developed countries. Keywords: Bovine brucellosis, RBT, Epidemiology, Public Health, Nigeri

JET machine operations in T&D-T

JET, the world's largest operating tokamak with unique Be/W wall and tritium handling capability, completed a Deuterium-Tritium (D-T) campaign in 2021 (Maggi et al 29th Fusion Energy Conf.) following a decade of preparatory experiments, dedicated enhancements, technical rehearsals and training (Horton et al 2016 Fusion Eng. Des. 109-111 925). Operation with tritium raises significant technical, safety and scientific challenges not encountered in standard protium or deuterium operation. This contribution describes the tritium operational requirements, pulses and technical preparations, new operating procedures, lessons learned and details on the achieved operational availability and performance. The preparation and execution of the recent JET tritium experiments benefitted from the previous experience in 1991 (Preliminary Tritium Experiment), 1997 (DTE1 campaign) and 2003 (Trace Tritium Campaigns) and consisted of the following five phases: technical rehearsals and scenario preparation, tritium commissioning, 100% tritium campaign, D-T campaign (DTE2), tritium clean-up. Following the clean-up JET resumed normal operation and is currently undertaking a further D-T campaign (DTE3)

Worldwide trends in underweight and obesity from 1990 to 2022: a pooled analysis of 3663 population-representative studies with 222 million children, adolescents, and adults

Background Underweight and obesity are associated with adverse health outcomes throughout the life course. We estimated the individual and combined prevalence of underweight or thinness and obesity, and their changes, from 1990 to 2022 for adults and school-aged children and adolescents in 200 countries and territories. Methods We used data from 3663 population-based studies with 222 million participants that measured height and weight in representative samples of the general population. We used a Bayesian hierarchical model to estimate trends in the prevalence of different BMI categories, separately for adults (age ≥20 years) and school-aged children and adolescents (age 5–19 years), from 1990 to 2022 for 200 countries and territories. For adults, we report the individual and combined prevalence of underweight (BMI <18·5 kg/m2) and obesity (BMI ≥30 kg/m2). For schoolaged children and adolescents, we report thinness (BMI <2 SD below the median of the WHO growth reference) and obesity (BMI >2 SD above the median). Findings From 1990 to 2022, the combined prevalence of underweight and obesity in adults decreased in 11 countries (6%) for women and 17 (9%) for men with a posterior probability of at least 0·80 that the observed changes were true decreases. The combined prevalence increased in 162 countries (81%) for women and 140 countries (70%) for men with a posterior probability of at least 0·80. In 2022, the combined prevalence of underweight and obesity was highest in island nations in the Caribbean and Polynesia and Micronesia, and countries in the Middle East and north Africa. Obesity prevalence was higher than underweight with posterior probability of at least 0·80 in 177 countries (89%) for women and 145 (73%) for men in 2022, whereas the converse was true in 16 countries (8%) for women, and 39 (20%) for men. From 1990 to 2022, the combined prevalence of thinness and obesity decreased among girls in five countries (3%) and among boys in 15 countries (8%) with a posterior probability of at least 0·80, and increased among girls in 140 countries (70%) and boys in 137 countries (69%) with a posterior probability of at least 0·80. The countries with highest combined prevalence of thinness and obesity in school-aged children and adolescents in 2022 were in Polynesia and Micronesia and the Caribbean for both sexes, and Chile and Qatar for boys. Combined prevalence was also high in some countries in south Asia, such as India and Pakistan, where thinness remained prevalent despite having declined. In 2022, obesity in school-aged children and adolescents was more prevalent than thinness with a posterior probability of at least 0·80 among girls in 133 countries (67%) and boys in 125 countries (63%), whereas the converse was true in 35 countries (18%) and 42 countries (21%), respectively. In almost all countries for both adults and school-aged children and adolescents, the increases in double burden were driven by increases in obesity, and decreases in double burden by declining underweight or thinness. Interpretation The combined burden of underweight and obesity has increased in most countries, driven by an increase in obesity, while underweight and thinness remain prevalent in south Asia and parts of Africa. A healthy nutrition transition that enhances access to nutritious foods is needed to address the remaining burden of underweight while curbing and reversing the increase in obesit

Global variation in diabetes diagnosis and prevalence based on fasting glucose and hemoglobin A1c

Fasting plasma glucose (FPG) and hemoglobin A1c (HbA1c) are both used to diagnose diabetes, but these measurements can identify different people as having diabetes. We used data from 117 population-based studies and quantified, in different world regions, the prevalence of diagnosed diabetes, and whether those who were previously undiagnosed and detected as having diabetes in survey screening, had elevated FPG, HbA1c or both. We developed prediction equations for estimating the probability that a person without previously diagnosed diabetes, and at a specific level of FPG, had elevated HbA1c, and vice versa. The age-standardized proportion of diabetes that was previously undiagnosed and detected in survey screening ranged from 30% in the high-income western region to 66% in south Asia. Among those with screen-detected diabetes with either test, the age-standardized proportion who had elevated levels of both FPG and HbA1c was 29-39% across regions; the remainder had discordant elevation of FPG or HbA1c. In most low- and middle-income regions, isolated elevated HbA1c was more common than isolated elevated FPG. In these regions, the use of FPG alone may delay diabetes diagnosis and underestimate diabetes prevalence. Our prediction equations help allocate finite resources for measuring HbA1c to reduce the global shortfall in diabetes diagnosis and surveillance

Worldwide trends in diabetes prevalence and treatment from 1990 to 2022: a pooled analysis of 1108 population-representative studies with 141 million participants

Background: Diabetes can be detected at the primary health-care level, and effective treatments lower the risk of complications. There are insufficient data on the coverage of treatment for diabetes and how it has changed. We estimated trends from 1990 to 2022 in diabetes prevalence and treatment for 200 countries and territories. Methods: We used data from 1108 population-representative studies with 141 million participants aged 18 years and older with measurements of fasting glucose and glycated haemoglobin (HbA1c), and information on diabetes treatment. We defined diabetes as having a fasting plasma glucose (FPG) of 7·0 mmol/L or higher, having an HbA1c of 6·5% or higher, or taking medication for diabetes. We defined diabetes treatment as the proportion of people with diabetes who were taking medication for diabetes. We analysed the data in a Bayesian hierarchical meta-regression model to estimate diabetes prevalence and treatment. Findings: In 2022, an estimated 828 million (95% credible interval [CrI] 757-908) adults (those aged 18 years and older) had diabetes, an increase of 630 million (554-713) from 1990. From 1990 to 2022, the age-standardised prevalence of diabetes increased in 131 countries for women and in 155 countries for men with a posterior probability of more than 0·80. The largest increases were in low-income and middle-income countries in southeast Asia (eg, Malaysia), south Asia (eg, Pakistan), the Middle East and north Africa (eg, Egypt), and Latin America and the Caribbean (eg, Jamaica, Trinidad and Tobago, and Costa Rica). Age-standardised prevalence neither increased nor decreased with a posterior probability of more than 0·80 in some countries in western and central Europe, sub-Saharan Africa, east Asia and the Pacific, Canada, and some Pacific island nations where prevalence was already high in 1990; it decreased with a posterior probability of more than 0·80 in women in Japan, Spain, and France, and in men in Nauru. The lowest prevalence in the world in 2022 was in western Europe and east Africa for both sexes, and in Japan and Canada for women, and the highest prevalence in the world in 2022 was in countries in Polynesia and Micronesia, some countries in the Caribbean and the Middle East and north Africa, as well as Pakistan and Malaysia. In 2022, 445 million (95% CrI 401-496) adults aged 30 years or older with diabetes did not receive treatment (59% of adults aged 30 years or older with diabetes), 3·5 times the number in 1990. From 1990 to 2022, diabetes treatment coverage increased in 118 countries for women and 98 countries for men with a posterior probability of more than 0·80. The largest improvement in treatment coverage was in some countries from central and western Europe and Latin America (Mexico, Colombia, Chile, and Costa Rica), Canada, South Korea, Russia, Seychelles, and Jordan. There was no increase in treatment coverage in most countries in sub-Saharan Africa; the Caribbean; Pacific island nations; and south, southeast, and central Asia. In 2022, age-standardised treatment coverage was lowest in countries in sub-Saharan Africa and south Asia, and treatment coverage was less than 10% in some African countries. Treatment coverage was 55% or higher in South Korea, many high-income western countries, and some countries in central and eastern Europe (eg, Poland, Czechia, and Russia), Latin America (eg, Costa Rica, Chile, and Mexico), and the Middle East and north Africa (eg, Jordan, Qatar, and Kuwait). Interpretation: In most countries, especially in low-income and middle-income countries, diabetes treatment has not increased at all or has not increased sufficiently in comparison with the rise in prevalence. The burden of diabetes and untreated diabetes is increasingly borne by low-income and middle-income countries. The expansion of health insurance and primary health care should be accompanied with diabetes programmes that realign and resource health services to enhance the early detection and effective treatment of diabetes